Liu Tong-Zu, Li Bing, Zhang Yong, Li Bo, Wang Wei, Wang Yong-Zhi, Zuo Ying-Tong, Wang Xing-Huan, Wu Zhong-Hua
Department of Urology, Zhongnan Hospital of Wuhan University, Dong Hu Road 169, Wu Chang District, Wuhan, 430071, Wuhan, China.
Institute of Urology, Wuhan University, Wuhan, China.
BMC Urol. 2025 May 15;25(1):124. doi: 10.1186/s12894-025-01814-7.
This study aims to evaluate the effectiveness of upper pole calyx fornix subapical puncture in percutaneous nephrolithotomy (PCNL) compared to traditional middle calyx puncture. The subapical puncture technique offers the advantages of upper pole access while minimizing the risk of pleural injury.
We conducted a retrospective analysis of 194 patients who underwent PCNL at our hospital from May 2022 to November 2023. Patients were divided into two groups based on puncture technique: the Upper-PCNL group (n = 122) with upper pole calyx fornix subapical puncture and the Mid-PCNL group (n = 72) with middle calyx fornix apex puncture. Data collected included tract establishment time, operative time, stone-free rates, complications, and auxiliary procedures.
The Upper-PCNL group demonstrated significantly higher primary stone-free rates (83.6% vs. 69.4%, P = 0.021) and shorter operative times (59.99 ± 5.85 min vs. 68.49 ± 6.74 min, P < 0.001) compared to the Mid-PCNL group. Tract establishment time was also significantly shorter in the Upper-PCNL group (3.06 ± 0.35 min vs. 3.56 ± 0.66 min, P < 0.001). The hemoglobin drop was not significantly different between the groups. Complication rates were minimal and similar between groups. None of the patients in the Upper-PCNL group experienced pleural, liver, or spleen injuries.
Upper pole calyx fornix subapical puncture achieved higher stone-free rates and shorter operative times compared to middle calyx puncture, with comparable safety profiles. Prospective trials are needed to validate these findings.
本研究旨在评估经皮肾镜取石术(PCNL)中肾上盏穹窿尖下穿刺与传统中盏穿刺相比的有效性。尖下穿刺技术具有肾上盏入路的优势,同时将胸膜损伤风险降至最低。
我们对2022年5月至2023年11月在我院接受PCNL的194例患者进行了回顾性分析。根据穿刺技术将患者分为两组:上盏PCNL组(n = 122)采用肾上盏穹窿尖下穿刺,中盏PCNL组(n = 72)采用中盏穹窿尖穿刺。收集的数据包括通道建立时间、手术时间、结石清除率、并发症和辅助操作。
与中盏PCNL组相比,上盏PCNL组的首次结石清除率显著更高(83.6%对69.4%,P = 0.021),手术时间更短(59.99 ± 5.85分钟对68.49 ± 6.74分钟,P < 0.001)。上盏PCNL组的通道建立时间也显著更短(3.06 ± 0.35分钟对3.56 ± 0.66分钟,P < 0.001)。两组之间血红蛋白下降无显著差异。并发症发生率极低且两组相似。上盏PCNL组的患者均未发生胸膜、肝脏或脾脏损伤。
与中盏穿刺相比,肾上盏穹窿尖下穿刺实现了更高的结石清除率和更短的手术时间,安全性相当。需要进行前瞻性试验来验证这些发现。